|
|
|
Insider
Information: |
Chopas James George |
Relationship: |
VP/Chief Accounting Of... |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
45,584 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,774,510 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
45,584 |
|
|
Total
Value |
$1,774,510 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Radius Health Inc. |
RDUS |
Principal Finance Acco... |
2021-03-05 |
6,701 |
|
0 |
Premium* |
|
Apellis Pharmaceuticals Inc |
APLS |
VP/Chief Accounting Of... |
2024-03-15 |
38,883 |
2021-08-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2024-03-15 |
4 |
S |
$56.46 |
$10,389 |
D/D |
(184) |
38,883 |
0 |
% |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2024-01-22 |
4 |
S |
$65.00 |
$68,961 |
D/D |
(1,061) |
39,067 |
0 |
% |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2024-01-16 |
4 |
S |
$66.81 |
$57,723 |
D/D |
(864) |
40,128 |
0 |
% |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,312 |
40,992 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2023-10-23 |
4 |
S |
$46.04 |
$6,077 |
D/D |
(132) |
32,680 |
0 |
% |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2023-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
32,812 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2023-02-21 |
4 |
D |
$58.50 |
$19,539 |
D/D |
(334) |
30,863 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,044 |
31,197 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2023-01-20 |
4 |
D |
$52.05 |
$47,834 |
D/D |
(919) |
27,153 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,621 |
28,072 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2022-10-20 |
4 |
D |
$58.00 |
$7,540 |
D/D |
(130) |
18,451 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2022-08-30 |
4 |
D |
$58.84 |
$32,833 |
D/D |
(558) |
18,581 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2022-01-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,657 |
19,139 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2022-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,974 |
15,456 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
VP/Chief Accounting Officer |
|
2021-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
882 |
8,482 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
See Remarks |
|
2021-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,600 |
7,600 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Principal Finance Accounting |
|
2021-03-05 |
4 |
S |
$20.88 |
$7,726 |
D/D |
(370) |
6,701 |
0 |
% |
|
RDUS |
Radius Health Inc. |
Principal Finance AccountingOf |
|
2020-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,492 |
|
% |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|